No Data
No Data
Noxopharm Advances Sofra Platform Commercialisation With Multiple Material Transfer Agreements
Noxopharm Joins Alliance for MRNA Medicines; Shares Up Nearly 7%
Noxopharm and UniSA Receive Tour De Cure Grant for Brain Cancer Research | ASX:NOX, OTC:NOXOF
Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug
Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive
Noxopharm Extends Strategic Partnership With Hudson Institute of Medical Research
No Data